Roche operates at the intersection of pharmaceutical innovation and diagnostics at scale โ 10,000+ employees across 25+ countries, with hiring accelerating across healthcare, sales, engineering, and manufacturing. The stack reveals dual operational tracks: modern cloud-native development (React, TypeScript, AWS, Kubernetes) for digital products alongside enterprise manufacturing systems (SAP S/4HANA, MES, LIMS, QMS). Active migration toward Veeva and LabVantage signals a shift toward specialized life-sciences compliance tooling, while persistent pain points around GMP compliance, data governance, and patient journey gaps suggest friction between legacy manufacturing operations and the personalized healthcare strategy the company publicly advocates.
Notable leadership hires: Chief Accountant, Shift Lead, Market Access Medical Affairs Lead, Procurement Lead, Medical Director
Roche is a public, Switzerland-headquartered pharmaceutical and diagnostics company with 10,000+ employees. The business spans oncology, immunology, infectious diseases, ophthalmology, CNS disorders, diabetes management, and in vitro diagnostics. The company markets itself around personalized healthcare โ fitting treatment to individual patient profiles โ and has embedded 30 medicines in WHO Essential Medicines lists. Manufacturing and quality compliance (GMP, audit readiness, regulatory adherence) occupy significant operational effort, evidenced by hiring in manufacturing (133 roles), research (97), and data (89), and by active projects in QMS implementation, facility design, and global pricing strategy. Sales and healthcare departments account for 458 of 1,714 active roles, indicating sustained commercial expansion.
Roche uses React, Next.js, TypeScript, and Python for development; AWS (Lambda, CodePipeline, CodeBuild, CodeDeploy), Kubernetes, and Docker for infrastructure; SAP S/4HANA, SAP FI, and SAP Tax for enterprise finance; and LIMS, MES, and QMS for manufacturing and lab operations.
Top projects include QMS implementation in China, study startup strategy, global value-based pricing strategy, disease full-cycle management, process automation, new facility design and construction, and academic conference organization for treatment fields.
Other companies in the same industry, closest in size